Patent details

EP1239879 Title: FORMULATIONS OF ADENOSINE A1 AGONISTS AND COX2-INHIBITORS

Basic Information

Publication number:
EP1239879
PCT Application Number:
PCT/GB/2000/004883
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009856279
PCT Publication Number:
WO/2001/045683
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS OF ADENOSINE A1 AGONISTS AND COX2-INHIBITORS
French Title of Invention:
FORMULATIONS D'AGONISTES DE L'ADENOSINE A1 ET D'INHIBITEURS DE COX2
German Title of Invention:
ZUSAMMENSETZUNGEN VON ADENOSIN A1 AGONISTEN UND COX2-HEMMERN
SPC Number:

Dates

Filing date:
19/12/2000
Grant date:
25/02/2004
EP Publication Date:
25/02/2004
PCT Publication Date:
28/06/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/09/0006
EP B1 Publication Date:
25/02/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/12/2004
Expiration date:
19/12/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/12/2000
 
 

Name:
GLAXO GROUP LIMITED
Address:
Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Inventor

1

Name:
NAYLOR Alan Glaxo Wellcome plc
Address:
United Kingdom (GB)

2

Name:
BOUNTRA Charanjit Glaxo Wellcome plc
Address:
United Kingdom (GB)

3

Name:
CLAYTON Nicholas, Maughan Glaxo Wellcome plc
Address:
United Kingdom (GB)

Priority

Priority Number:
9930075
Priority Date:
20/12/1999
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 45/06;
Filing date Document type Number of pages